4896.T
K Pharma,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 799.00
+0.88%Aug 14, 2026, 05:14 UTC
K Pharma extended its joint research agreement with National Hospital Organization Osaka Medical Center for chronic cerebral infarction regenerative medicine products until March 31, 2029.
Source:Aug 14, 2026, 05:14 UTC
K Pharma extended its joint research agreement with Kitasato Institute for hearing loss research until March 2027.
Source:Aug 12, 2026, 23:30 UTC
K Pharma reported its Q2 FY2026 results on August 13, showing a narrowed net loss of 240 million yen for April-June, while the first-half cumulative net loss widened to 490 million yen.
Source: